Hydroxylamine derivatives for the treatment of stroke

Details for Australian Patent Application No. 2007328280 (hide)

Owner CytRx Corporation

Inventors Barber, Jack R.

Agent Davies Collison Cave

Pub. Number AU-A-2007328280

PCT Pub. Number WO2008/070010

Priority 60/872,329 01.12.06 US; 60/920,396 27.03.07 US; 60/993,848 14.09.07 US

Filing date 30 November 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/4545 (2006.01)

A61K 31/5395 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. oxadiazines

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/070010 Priority application(s): WO2008/070010

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007328281-Combination of an HDAC inhibitor and an antimetabolite

2007328267-Substituted diazepan compounds as orexin receptor antagonists